Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Direct Measurements of Cardiometabolic Risk in Treated Schizophrenia Patients

NCT00501163 is registered in ClinicalTrials.gov with Washington University School of Medicine as lead sponsor.

NCT NCT00501163
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00501163 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Direct Measurements of Cardiometabolic Risk in Treated Schizophrenia Patients
Lead sponsor
Washington University School of Medicine
Phase
Observational
Overall status
Completed
Start date
August 31, 2007
Completion date
May 31, 2012
Enrollment
38 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cardiovascular disease, schizophrenia